Lyxor EuroMTS 10-15Y Investment Grade (DR) UCITS ETF is a bonds ETF from Amundi tracking the Multi Units Luxembourg - Lyxor EuroMTS 10-15Y Investment Grade index through physical replication. Domiciled in Luxembourg and launched in 2017, the fund manages about 1 bn € and charges a TER of 0.17% — 17 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Lyxor EuroMTS 10-15Y Investment Grade (DR) UCITS ETF competes with 1 other products on the same index (Multi Units Luxembourg - Lyxor EuroMTS 10-15Y Investment Grade): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.17% against a group median of 0.17%. It has been listed since 2017, 9 years of track record.
On a €10,000 investment the TER costs 17 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 47.6% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| France (Republic Of) 5.75% | 7.7% |
| France (Republic Of) 4.75% | 6.3% |
| Germany (Federal Republic Of) 4.75% | 5.6% |
| France (Republic Of) 1.25% | 5.5% |
| Italy (Republic Of) | 5.1% |
| Spain (Kingdom of) 5.75% | 5.0% |
| Belgium (Kingdom Of) | 4.4% |
| Italy (Republic Of) 5.75% | 4.4% |
| Italy (Republic Of) 1.65% | 3.6% |
| Borsa Italiana | EM1015 | EUR |
| XETRA | LYQ6 | EUR |
| Francoforte | LYQ6 | EUR |
| Euronext Paris | MTE | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.